Gene · 10332
Papers1,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interaction between hTIM-1 and Envelope Protein Is Important for JEV Infection. | Viruses | 2023 | 37515282 | PubTator, text mining | PubMed |
| Relevance of Host Cell Surface Glycan Structure for Cell Specificity of Influenza A Viruses. | Viruses | 2023 | 37515193 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies. | Viruses | 2023 | 37515187 | PubTator, text mining | PubMed |
| Exploring the Immunomodulatory Properties of Stem Cells in Combating COVID-19: Can We Expect More? | Bioengineering (Basel) | 2023 | 37508830 | PubTator, text mining | PubMed |
| Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy? | Genes Dis | 2023 | 37492721 | PubTator, text mining | PubMed |
| Improvement of variables interpretability in kernel PCA. | BMC Bioinformatics | 2023 | 37438763 | PubTator, text mining | PubMed |
| Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. | bioRxiv | 2023 | 37425811 | PubTator, text mining | PubMed |
| Physicochemical Nature of SARS-CoV-2 Spike Protein Binding to Human Vimentin. | ACS Appl Mater Interfaces | 2023 | 37413693 | PubTator, text mining | PubMed |
| Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications. | Trends Immunol | 2023 | 37407365 | PubTator, text mining | PubMed |
| California Serogroup Viruses in a Changing Canadian Arctic: A Review. | Viruses | 2023 | 37376542 | PubTator, text mining | PubMed |
| Towards Understanding Long COVID: SARS-CoV-2 Strikes the Host Cell Nucleus. | Pathogens | 2023 | 37375496 | PubTator, text mining | PubMed |
| Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy. | Cells | 2023 | 37371134 | PubTator, text mining | PubMed |
| Managing Relevant Clinical Conditions of Hemophilia A/B Patients. | Hematol Rep | 2023 | 37367088 | PubTator, text mining | PubMed |
| [Myocardial injury caused by infection of coronavirus]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2023 | 37366137 | PubTator, text mining | PubMed |
| SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight. | Virusdisease | 2023 | 37363363 | PubTator, text mining | PubMed |
| COVID-19db linkage maps of cell surface proteins and transcription factors in immune cells. | J Med Virol | 2023 | 37341527 | PubTator, text mining | PubMed |
| Role and clinical implication of autophagy in COVID-19. | Virol J | 2023 | 37328875 | PubTator, text mining | PubMed |
| Anticoagulant therapy in COVID-19: A narrative review. | Clin Transl Sci | 2023 | 37326220 | PubTator, text mining | PubMed |
| Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. | Signal Transduct Target Ther | 2023 | 37286535 | PubTator, text mining | PubMed |
| Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells. | Pathogens | 2023 | 37242317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10332/papers?page=6